Reliable change in neuropsychological assessment of breast cancer survivors

Charissa Andreotti, James C. Root, Sanne B. Schagen, Brenna McDonald, Andrew Saykin, Thomas M. Atkinson, Yuelin Li, Tim A. Ahles

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background The purpose of this study was to enhance the current understanding and interpretation of longitudinal change on tests of neurocognitive function in individuals with cancer. Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error. Methods The current study assessed the test-retest reliability of several tests and overarching cognitive domains comprising a neurocognitive battery typical of those used for research and clinical evaluation using relevant time frames. Practice effect-adjusted reliable change confidence intervals for test-retest difference scores based on a sample of patient-matched healthy controls are provided. Results By applying reliable change confidence intervals to scores from two samples of breast cancer patients at post-treatment follow-up assessment, meaningful levels of detectable change in cognitive functioning in breast cancer survivors were ascertained and indicate that standardized neuropsychological instruments may be subject to limitations in detection of subtle cognitive dysfunction over clinically relevant intervals, especially in patient samples with average to above average range baseline functioning. Conclusions These results are discussed in relation to reported prevalence of cognitive change in breast cancer patients along with recommendations for study designs that enhance detection of treatment effects.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalPsycho-Oncology
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Survivors
Breast Neoplasms
Confidence Intervals
Reproducibility of Results
Therapeutics
Neoplasms

Keywords

  • breast cancer
  • cognition
  • neuropsychological assessment
  • survivorship

ASJC Scopus subject areas

  • Oncology
  • Psychiatry and Mental health
  • Experimental and Cognitive Psychology

Cite this

Andreotti, C., Root, J. C., Schagen, S. B., McDonald, B., Saykin, A., Atkinson, T. M., ... Ahles, T. A. (2016). Reliable change in neuropsychological assessment of breast cancer survivors. Psycho-Oncology, 25(1), 43-50. https://doi.org/10.1002/pon.3799

Reliable change in neuropsychological assessment of breast cancer survivors. / Andreotti, Charissa; Root, James C.; Schagen, Sanne B.; McDonald, Brenna; Saykin, Andrew; Atkinson, Thomas M.; Li, Yuelin; Ahles, Tim A.

In: Psycho-Oncology, Vol. 25, No. 1, 01.01.2016, p. 43-50.

Research output: Contribution to journalArticle

Andreotti, C, Root, JC, Schagen, SB, McDonald, B, Saykin, A, Atkinson, TM, Li, Y & Ahles, TA 2016, 'Reliable change in neuropsychological assessment of breast cancer survivors', Psycho-Oncology, vol. 25, no. 1, pp. 43-50. https://doi.org/10.1002/pon.3799
Andreotti, Charissa ; Root, James C. ; Schagen, Sanne B. ; McDonald, Brenna ; Saykin, Andrew ; Atkinson, Thomas M. ; Li, Yuelin ; Ahles, Tim A. / Reliable change in neuropsychological assessment of breast cancer survivors. In: Psycho-Oncology. 2016 ; Vol. 25, No. 1. pp. 43-50.
@article{55cbdff794d2455bb2cb0d2d4e0a4f95,
title = "Reliable change in neuropsychological assessment of breast cancer survivors",
abstract = "Background The purpose of this study was to enhance the current understanding and interpretation of longitudinal change on tests of neurocognitive function in individuals with cancer. Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error. Methods The current study assessed the test-retest reliability of several tests and overarching cognitive domains comprising a neurocognitive battery typical of those used for research and clinical evaluation using relevant time frames. Practice effect-adjusted reliable change confidence intervals for test-retest difference scores based on a sample of patient-matched healthy controls are provided. Results By applying reliable change confidence intervals to scores from two samples of breast cancer patients at post-treatment follow-up assessment, meaningful levels of detectable change in cognitive functioning in breast cancer survivors were ascertained and indicate that standardized neuropsychological instruments may be subject to limitations in detection of subtle cognitive dysfunction over clinically relevant intervals, especially in patient samples with average to above average range baseline functioning. Conclusions These results are discussed in relation to reported prevalence of cognitive change in breast cancer patients along with recommendations for study designs that enhance detection of treatment effects.",
keywords = "breast cancer, cognition, neuropsychological assessment, survivorship",
author = "Charissa Andreotti and Root, {James C.} and Schagen, {Sanne B.} and Brenna McDonald and Andrew Saykin and Atkinson, {Thomas M.} and Yuelin Li and Ahles, {Tim A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/pon.3799",
language = "English (US)",
volume = "25",
pages = "43--50",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Reliable change in neuropsychological assessment of breast cancer survivors

AU - Andreotti, Charissa

AU - Root, James C.

AU - Schagen, Sanne B.

AU - McDonald, Brenna

AU - Saykin, Andrew

AU - Atkinson, Thomas M.

AU - Li, Yuelin

AU - Ahles, Tim A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background The purpose of this study was to enhance the current understanding and interpretation of longitudinal change on tests of neurocognitive function in individuals with cancer. Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error. Methods The current study assessed the test-retest reliability of several tests and overarching cognitive domains comprising a neurocognitive battery typical of those used for research and clinical evaluation using relevant time frames. Practice effect-adjusted reliable change confidence intervals for test-retest difference scores based on a sample of patient-matched healthy controls are provided. Results By applying reliable change confidence intervals to scores from two samples of breast cancer patients at post-treatment follow-up assessment, meaningful levels of detectable change in cognitive functioning in breast cancer survivors were ascertained and indicate that standardized neuropsychological instruments may be subject to limitations in detection of subtle cognitive dysfunction over clinically relevant intervals, especially in patient samples with average to above average range baseline functioning. Conclusions These results are discussed in relation to reported prevalence of cognitive change in breast cancer patients along with recommendations for study designs that enhance detection of treatment effects.

AB - Background The purpose of this study was to enhance the current understanding and interpretation of longitudinal change on tests of neurocognitive function in individuals with cancer. Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error. Methods The current study assessed the test-retest reliability of several tests and overarching cognitive domains comprising a neurocognitive battery typical of those used for research and clinical evaluation using relevant time frames. Practice effect-adjusted reliable change confidence intervals for test-retest difference scores based on a sample of patient-matched healthy controls are provided. Results By applying reliable change confidence intervals to scores from two samples of breast cancer patients at post-treatment follow-up assessment, meaningful levels of detectable change in cognitive functioning in breast cancer survivors were ascertained and indicate that standardized neuropsychological instruments may be subject to limitations in detection of subtle cognitive dysfunction over clinically relevant intervals, especially in patient samples with average to above average range baseline functioning. Conclusions These results are discussed in relation to reported prevalence of cognitive change in breast cancer patients along with recommendations for study designs that enhance detection of treatment effects.

KW - breast cancer

KW - cognition

KW - neuropsychological assessment

KW - survivorship

UR - http://www.scopus.com/inward/record.url?scp=84955439822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955439822&partnerID=8YFLogxK

U2 - 10.1002/pon.3799

DO - 10.1002/pon.3799

M3 - Article

C2 - 25808921

AN - SCOPUS:84955439822

VL - 25

SP - 43

EP - 50

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 1

ER -